Our findings indicate that a physiological alteration of the R466/K467 site in cells mimicking the effect of the mutant 466 A/467 A, and altering the binding to PtdSer or PtdIns(4,5)P2, would lead to the constitutive activation of PDK1 and potentially to a significant effect in different types of cancer. Here, PDK1 is linked to cancer.